ArriVent BioPharma, Inc.

AVBP

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001868279

SEC filings (opens in a new tab)

No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.60B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q1 2026 vs. Q4 2025

How the institutions holding ArriVent BioPharma, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of AVBP: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	122	1	139	+18
Shares	40.1M	1.87M	42.1M	+3.85M (+10.1%)
Value	$810.3M	$37.6M	$969.5M	+$196.8M (+25.5%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held ArriVent BioPharma, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to AVBP in Q1 2026
Institution	Shares	Value	% of portfolio
Vanguard Capital Management LLC	1,528,893	$35.3M	0.00%
Vivo Capital, LLC	885,916	$20.4M	1.70%
Logos Global Management LP	350,000	$8.07M	0.42%
Vanguard Portfolio Management LLC	253,852	$5.86M	0.00%
Nomura Holdings Inc	242,050	$5.58M	0.05%
Vanguard Fiduciary Trust Co	217,127	$5.01M	0.00%
ADAR1 Capital Management, LLC	141,814	$3.27M	0.20%
Polymer Capital Management (HK) LTD	122,276	$2.82M	0.40%
E Fund Management Co., Ltd.	93,953	$2.17M	0.06%
Qube Research & Technologies Ltd	70,317	$1.62M	0.00%
Seven Fleet Capital Management LP	50,252	$1.16M	0.36%
Jones Hill Capital LP	45,809	$1.06M	0.23%
Quantinno Capital Management LP	30,996	$715.1K	0.00%
CI Private Wealth, LLC	27,239	$607.8K	0.00%
Tudor Investment Corp Et Al	22,101	$509.9K	0.00%
Man Group plc	20,727	$478.2K	0.00%
American Century Companies Inc	19,515	$450.2K	0.00%
Optimize Financial Inc	18,916	$436.4K	0.21%
IvyRock Asset Management (HK) Ltd	16,000	$369.1K	0.21%
Caption Management, LLC	15,967	$368.4K	0.02%
Voya Investment Management LLC	15,331	$353.7K	0.00%
Vanguard Asset Management, Ltd	14,893	$343.6K	0.00%
Skopos Labs, Inc.	14,125	$325.9K	0.01%
Susquehanna Portfolio Strategies, LLC	12,252	$282.7K	0.00%
Vanguard Global Advisers, LLC	10,763	$248.3K	0.00%
Manufacturers Life Insurance Company, The	9,068	$209.2K	0.00%
Glenmede Trust Co NA	9,061	$209.0K	0.00%
Axq Capital, LP	8,935	$206.1K	0.03%
Vanguard Investments Australia, Ltd.	6,077	$140.2K	0.00%
Quantbot Technologies LP	534	$12.3K	0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	494	$11.4K	0.00%
Parallel Advisors, LLC	24	$554	0.00%
MAI Capital Management	19	$439	0.00%
Root Financial Partners, LLC	18	$415	0.00%
Keating Financial Advisory Services, Inc.	1	$23	0.00%

Sold out (17)

Institutions that held ArriVent BioPharma, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of AVBP in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
AIHC Capital Management Ltd	644,788	$13.0M
Rosalind Advisors, Inc.	215,871	$4.34M
Hidden Lake Asset Management LP	152,448	$3.07M
Simplex Trading, LLC	45,558	$916.6K
Two Sigma Advisers, LP	37,100	$746.5K
Anson Funds Management LP	35,366	$711.6K
NEOS Investment Management LLC	32,487	$653.6K
Tema ETFs LLC	32,007	$644.0K
Walleye Capital LLC	22,115	$445.0K
Brevan Howard Capital Management LP	16,635	$334.7K
Virtu Financial LLC	11,300	$227.0K
Group One Trading, L.P.	2,854	$57.4K
Quest Partners LLC	2,800	$56.3K
Amalgamated Bank	927	$19.0K
DV Trading LLC	683	$13.7K
Daiwa Securities Group Inc.	111	$2.00K
Aster Capital Management (DIFC) Ltd	73	$1.47K

Not filed for Q1 2026 yet (1)

Institutions that held ArriVent BioPharma, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AVBP in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	1,869,266	$37.6M